Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
08/14/2003 | WO2002029055A3 Carbohydrate-associated proteins |
08/14/2003 | WO2001092527A3 Regulators of apoptosis |
08/14/2003 | US20030153849 Method and apparatus for connective tissue treatment |
08/14/2003 | US20030153750 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
08/14/2003 | US20030153736 Diagnosis and prognosis and radiotherapy of metastatic bone disease |
08/14/2003 | US20030153732 Novel polypepetide |
08/14/2003 | US20030153627 Compounds for blocking androgen receptors |
08/14/2003 | US20030153625 Suppressing bone disordes such as decalcification or fractures in humans having prostate gland cancers by administering antiestrogen selected from triphenylethylene or toremifene; hormone inhibitors |
08/14/2003 | US20030153610 Substituted oxazolidinones and their in the field of blood coagulation |
08/14/2003 | US20030153606 Antiproliferative agents for treating adipocyte differentiation, cancer, osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease |
08/14/2003 | US20030153605 Enzyme inhibitors of nitric oxide synthase |
08/14/2003 | US20030153583 Solid-state forms of N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl) pyrazole |
08/14/2003 | US20030153575 Tetracyclic diketopiperazine compounds as pdev inhibitors |
08/14/2003 | US20030153569 Novel pyrazole and pyrazoline substituted compounds |
08/14/2003 | US20030153568 Serine/threonine and tyrosine kinases inhibitors |
08/14/2003 | US20030153559 Treatment of an oxygen and/or energy deficit; a poly(adenosine diphosphate ribose)-polymerase inhibitor; treating autoimmune, neurodegenerative and diseases caused by a toxic effect; viricides |
08/14/2003 | US20030153558 Immunomodulators and/or inhibiting cytokine release |
08/14/2003 | US20030153557 Treating osteoporosis, cardiovascular disorders, restenosis, arteriosclerosis, nephropathies or retinopathies; antitumor and antiinflammatory agents |
08/14/2003 | US20030153553 Quinoline derivatives |
08/14/2003 | US20030153549 Clavulinic acid derivatives; antibiotics |
08/14/2003 | US20030153536 Compounds and methods of treating transplant rejection |
08/14/2003 | US20030153525 Identifies differential expression of 1465, 1587, 2146, 2207, 32838, 336 OR 52908 genes in tissues relating to pain sensation relative to their expression in normal or non-painful disease states |
08/14/2003 | US20030153078 Method for in vitro production of three-dimensional vital cartilage or bone tissue and use thereof as transplant material |
08/14/2003 | US20030153073 Expansion of T cells in vitro and expanded T cell populations |
08/14/2003 | US20030153048 Novel proteins and methods for producing the proteins |
08/14/2003 | US20030152973 G-protein coupled receptor org3 |
08/14/2003 | US20030152947 Methods for detecting and treating the early onset of aging-related conditions |
08/14/2003 | US20030152651 Herbal composition for angina pectoris, method to prepare same and uses thereof |
08/14/2003 | US20030152600 Novel compounds of the n-acylamino-amide-family, cpmpositions comprising same, and uses |
08/14/2003 | US20030152594 Immunology response intensifiers; administering a bacterial lysate |
08/14/2003 | US20030152572 Blocking production of synoviocytes; antiinflammatory agents; prevent signal transduction |
08/14/2003 | CA2697599A1 Method of treating and preventing bone loss |
08/14/2003 | CA2485064A1 Albumin-fused kunitz domain peptides |
08/14/2003 | CA2476214A1 Proliferated cell lines and uses thereof |
08/14/2003 | CA2475767A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
08/14/2003 | CA2475637A1 Quinolinone derivatives for treating cell proliferation related disorders |
08/14/2003 | CA2475539A1 Hiv inhibiting proteins |
08/14/2003 | CA2475382A1 Albumin-fused anti-angiogenesis peptides |
08/14/2003 | CA2475329A1 Truncated aggrecanase molecules |
08/14/2003 | CA2475247A1 Anti-pathogen treatments |
08/14/2003 | CA2474974A1 Cytoprotective benzofuran derivatives |
08/14/2003 | CA2474919A1 Formulation comprising bioactive agents and method of using same |
08/14/2003 | CA2474917A1 Granzyme b inhibitors |
08/14/2003 | CA2474783A1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
08/14/2003 | CA2474748A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
08/14/2003 | CA2474508A1 Ansamycins having improved pharmacological and biological properties |
08/14/2003 | CA2474431A1 Method of treating and preventing bone loss |
08/14/2003 | CA2474283A1 Amino acid sequences capable of facilitating penetration across a biological barrier |
08/14/2003 | CA2474186A1 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
08/14/2003 | CA2474011A1 Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders |
08/14/2003 | CA2473778A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
08/14/2003 | CA2473182A1 Compositions and methods for treatment of vitamin d deficiency |
08/14/2003 | CA2473181A1 Quinoline derivatives as npy antagonists |
08/14/2003 | CA2467555A1 Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl)-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-me thyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections |
08/14/2003 | CA2466251A1 Therapeutic use of aziridino compounds |
08/14/2003 | CA2450807A1 Non-myeloablative tolerogenic treatment with tyrphostins |
08/13/2003 | EP1334972A1 Non-peptide compounds affecting the action of gonadotropin-releasing hormone (GnRH) |
08/13/2003 | EP1334718A1 Drug composition comprising dipeptydyl aldehyde derivative |
08/13/2003 | EP1334367A2 A method of determining the initial dose of vitamin d compounds |
08/13/2003 | EP1334088A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
08/13/2003 | EP1333853A1 Growth factor complex |
08/13/2003 | EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof |
08/13/2003 | EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof |
08/13/2003 | EP1333834A2 Antiinflammation agents |
08/13/2003 | EP1333833A2 Novel compounds |
08/13/2003 | EP1333827A2 Estrogen receptor modulators |
08/13/2003 | EP1333821A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
08/13/2003 | EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
08/13/2003 | EP1333808A2 Electroprocessed composition used in drug delivery and cell encapsulation |
08/13/2003 | EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists |
08/13/2003 | EP1222193B1 Imidazole derivatives as phosphodiesterase vii inhibitors |
08/13/2003 | EP1220845B1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors |
08/13/2003 | EP1140943B1 Substituted pyrroloindoles |
08/13/2003 | EP0971948B1 Inhibitors for urokinase receptor |
08/13/2003 | EP0904092B1 Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use |
08/13/2003 | EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
08/13/2003 | CN1436235A Anti-angiogenic polypeptides |
08/13/2003 | CN1436197A Novel compounds of N-acylamino-amide family, compositions comprising same and uses |
08/13/2003 | CN1436196A Pyridine-2-yl-aminoalkyl carbonyl glycyl-beta-alanine and derivs. thereof |
08/13/2003 | CN1436195A Integrin binding peptide derivatives |
08/13/2003 | CN1436192A HMG-CoA reductase inhibitors and method |
08/13/2003 | CN1436185A Thrombin receptor antagonists |
08/13/2003 | CN1436174A HMG-CoA reductase inhibitors and their use as medicaments for treatment of cholesterol related diseases |
08/13/2003 | CN1436168A Beta-amino acid nitrile derivs. |
08/13/2003 | CN1436086A Interferon for treatment of multiple sclerosis |
08/13/2003 | CN1436072A Composition, kits, and methods for promoting defined health benefits |
08/13/2003 | CN1435418A Aromatic nitrogen-contg. bis-phosphonic acid derivs., process for preparing same and use thereof |
08/13/2003 | CN1435256A Oral collagen Ôàí film preparation |
08/13/2003 | CN1435245A Capsule for alleviating pains of neck, shoulder waist and leg |
08/13/2003 | CN1435235A Medicinal liquid for activating meridians |
08/13/2003 | CN1435227A ÔÇ£QimahuojinwanÔÇØ pill for relaxing muscles and tendons |
08/13/2003 | CN1435219A Medicine for treating traumatic injury |
08/13/2003 | CN1435217A Bone-strengthening medicine and producing method thereof |
08/13/2003 | CN1435205A Medicine for treating rheumatoid arthritis and tetanic rachitis |
08/13/2003 | CN1435204A Medicine for treating protrusion of intervertebral disk and hyperplastic spondylitis |
08/13/2003 | CN1435195A Chinese medicine preparation for treating rheumatoid arthritis and preparing method thereof |
08/13/2003 | CN1435194A Chinese medicine preparation for treating ÔÇ£rheumatic four diseasesÔÇØ and preparing method thereof |
08/13/2003 | CN1435192A ÔÇ£JianzhoukangÔÇØ medicine for medicinal pillow for treating periomethritis and preparing method thereof |
08/13/2003 | CN1435191A Chinese medicine for bone-knitting and method for preparing same |
08/13/2003 | CN1435190A Meridians-activating pain-alleviating plaster for treating pains of neck, shoulder, waist and leg |